Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Replicel Life Sciences Inc
V.RP
Alternate Symbol(s):
REPCF
Technology
Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair...
restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Dec 29, 2022 10:55pm
Private Placement
Dec. 30th the Private Placement closes. It will be interesting to see if it was full subscribed. Possibly they have been holding off updating the trip to Japan until the PP closes. From
...more
(15)
•••
bluemoons20
X
View Profile
View Bullboard History
Comment by
bluemoons20
on Dec 26, 2022 9:01am
RE:RE:RE:Shares for Debt
Well , I guess if there was a time to average down , now would b it!! Tax loss season. However ,on the surprising side of this look at the
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(1)
•••
toniZ1
X
View Profile
View Bullboard History
Comment by
toniZ1
on Dec 24, 2022 4:42am
RE:RE:Shares for Debt
developments? you mean probabyl words, can't see any buisness development of relevance here. once again the only thing that counts is the shiseido topic. Better they get a cash than going
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Dec 23, 2022 3:12pm
RE:Shares for Debt
They would be wise to tweet some good news from Japan if there is any to offset this BS. Yes lets squeeze in this shares for debt right at the end of the year for tax purposes. It looks
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Dec 23, 2022 2:57pm
Shares for Debt
Here we go again. Question: Do we need some of these Directors when the company is running on fumes ? REPLICEL ANNOUNCES DEBT SETTLEMENT RepliCel Life Sciences Inc. intends to settle debt
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Dec 23, 2022 10:47am
RE:RE:CEO Busy
I am not sure if this business trip to Japan has been completed. I am hoping we get some sort of a tweet update regarding how things went. Anything at this point would be encouraging. They mentioned
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Dec 20, 2022 12:09pm
RE:CEO Busy
From Twitter: "RepliCel Life Sciences Inc.
...more
(2)
•••
ZeoGak
X
View Profile
View Bullboard History
Post by
ZeoGak
on Dec 19, 2022 8:21pm
CEO Busy
https://mobile.twitter.com/RepliCel/with_replies
(15)
•••
bluemoons20
X
View Profile
View Bullboard History
Comment by
bluemoons20
on Dec 19, 2022 7:23pm
RE:Drifting
lets hope you are right about closing the PP. might be hard to dell if market @ 0,085. Even though have seen some other stocks sell PP@ $1.20 when
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Dec 19, 2022 1:36pm
Drifting
As we look back on 2022 I can only describe it as painful and disappointing We started the year at $.26 with promise of the Dermal Injector receiving FDA Approval and and a positve conclusion to
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Dec 14, 2022 1:31pm
RE:What Next
It is pretty hard to sell a Private Placement at $.10 mind you with warrants when you can buy shares on the open market at $.09. I was a bit surprised that the update didn't spark a little
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Dec 13, 2022 7:53pm
What Next
From Stockwatch this afternoon: Mr. Lee Buckler Reports: "REPLICEL ANNOUNCES EXTENSION TO NON-BROKERED PRIVATE PLACEMENT The TSX Venture Exchange has granted a two-week extension until Dec.
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Dec 13, 2022 12:24pm
RE:Just something I look at
The question is when were the first injections in the study group ? From the report: "Based on the global photo assessment, photos will have to be taken at 12 months medications, and
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Dec 09, 2022 3:19pm
This Is Funny
These are the type of trades Replicel is getting: Recent Trades - All 1 today Time ET Ex
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >